Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea

Fig. 3

MITT treatment components dispensed immediately prior to initiation and following discontinuation of MITT. MITT was defined as concomitant use of two different inhalers in the form of ICS/LABA + LAMA or ICS + LABA/LAMA, or of three different inhalers in the form of ICS + LAMA + LABA. This figure includes medication with days' supply immediately prior to and immediately following MITT, and within 90 days of the first episode of MITT; results were based on pharmacy dispensing data. Patients may have been treated with more than one medication within a class. ICS: inhaled corticosteroids; LABA: long-acting beta agonist; LAMA: long-acting muscarinic antagonist; MITT: multiple inhaler triple therapy

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us